Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer von Hong, David S, Concin, Nicole, Vergote, Ignace, de Bono, Johann S, Slomovitz, Brian M, Drew, Yvette, Arkenau, Hendrik-Tobias, Machiels, Jean-Pascal, Spicer, James F, Jones, Robert, Forster, Martin D, Cornez, Nathalie, Gennigens, Christine, Johnson, Melissa L, Thistlethwaite, Fiona C, Rangwala, Reshma A, Ghatta, Srinivas, Windfeld, Kristian, Harris, Jeffrey R, Lassen, Ulrik Niels, Coleman, Robert L

Volltext

Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths... von Lai, Alvina G, Pasea, Laura, Banerjee, Amitava, Hall, Geoff, Denaxas, Spiros, Chang, Wai Hoong, Katsoulis, Michail, Williams, Bryan, Pillay, Deenan, Noursadeghi, Mahdad, Linch, David, Hughes, Derralynn, Forster, Martin D, Turnbull, Clare, Fitzpatrick, Natalie K, Boyd, Kathryn, Foster, Graham R, Enver, Tariq, Nafilyan, Vahe, Humberstone, Ben, Neal, Richard D, Cooper, Matt, Jones, Monica, Pritchard-Jones, Kathy, Sullivan, Richard, Davie, Charlie, Lawler, Mark, Hemingway, Harry

Volltext

Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1‒Positive, Advanced Non‒Small-Cell Lung Cancer in the KEYNOTE-010 Study von Herbst, Roy S, Garon, Edward B, Kim, Dong-Wan, Cho, Byoung Chul, Perez-Gracia, Jose L, Han, Ji-Youn, Arvis, Catherine Dubos, Majem, Margarita, Forster, Martin D, Monnet, Isabelle, Novello, Silvia, Szalai, Zsuzsanna, Gubens, Matthew A, Su, Wu-Chou, Ceresoli, Giovanni Luca, Samkari, Ayman, Jensen, Erin H, Lubiniecki, Gregory M, Baas, Paul

Volltext

Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation von Sacher, Adrian, LoRusso, Patricia, Patel, Manish R., Miller, Wilson H., Garralda, Elena, Forster, Martin D., Santoro, Armando, Falcon, Alejandro, Kim, Tae Won, Paz-Ares, Luis, Bowyer, Samantha, de Miguel, Maria, Han, Sae-Won, Krebs, Matthew G., Lee, Jong-Seok, Cheng, Michael L., Arbour, Kathryn, Massarelli, Erminia, Choi, Yoonha, Shi, Zhen, Mandlekar, Sandhya, Lin, Mark T., Royer-Joo, Stephanie, Chang, Julie, Dharia, Neekesh V., Schutzman, Jennifer L., Desai, Jayesh

Volltext

Cumulative burden of 144 conditions, critical care hospitalisation and premature mortality across 26 adult cancers von Chang, Wai Hoong, Neal, Richard D., Forster, Martin D., Lai, Alvina G.

Volltext

Reach and predictors of effects during nation-wide dissemination of the universal parenting program All Children in Focus von van Leuven, Livia, Engelbrektsson, Johanna, Forster, Martin

Volltext

De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies von Mehanna, Hisham, Rischin, Danny, Wong, Stuart J, Gregoire, Vincent, Ferris, Robert, Waldron, John, Le, Quynh-Thu, Forster, Martin, Gillison, Maura, Laskar, Sarbani, Tahara, Makoto, Psyrri, Amanda, Vermorken, Jan, Porceddu, Sandro

Volltext

Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study von Jamieson, Liz, Forster, Martin D, Zaki, Kam, Mithra, Sanjena, Alli, Heena, O'Connor, Anne, Patel, Apini, Wong, Ian C K, Chambers, Pinkie

Volltext

The National Lung Matrix Trial of personalized therapy in lung cancer von Middleton, Gary, Fletcher, Peter, Popat, Sanjay, Savage, Joshua, Summers, Yvonne, Greystoke, Alastair, Gilligan, David, Cave, Judith, O’Rourke, Noelle, Brewster, Alison, Toy, Elizabeth, Spicer, James, Jain, Pooja, Dangoor, Adam, Mackean, Melanie, Forster, Martin, Farley, Amanda, Wherton, Dee, Mehmi, Manita, Sharpe, Rowena, Mills, Tara C., Cerone, Maria Antonietta, Yap, Timothy A., Watkins, Thomas B. K., Lim, Emilia, Swanton, Charles, Billingham, Lucinda

Volltext

Incidence and predictive factors for positive non-sentinel lymph nodes in completion neck dissection following a positive sentinel node biopsy in early oral cancer von Karamchandani, Searan, Sahovaler, Axel, Crosbie-Jones, Elizabeth, McGurk, Mark, Thavaraj, Selvam, Alibhai, Mustansir, Wan, Simon, Forster, Martin D, Sassoon, Isabel, Schilling, Clare

Volltext

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial von Sandhu, Shahneen K, MD, Schelman, William R, MD, Wilding, George, MD, Moreno, Victor, MD, Baird, Richard D, PhD, Miranda, Susana, BSc, Hylands, Lucy, BSc, Riisnaes, Ruth, FIBMS, Forster, Martin, PhD, Omlin, Aurelius, MD, Kreischer, Nathan, MSc, Thway, Khin, MD, Gevensleben, Heidrun, MD, Sun, Linda, PhD, Loughney, John, PhD, Chatterjee, Manash, PhD, Toniatti, Carlo, PhD, Carpenter, Christopher L, MD, Iannone, Robert, MD, Kaye, Stan B, Prof, de Bono, Johann S, Prof, Wenham, Robert M

Volltext

The performance of a Bayesian value-based sequential clinical trial design in the presence of an equivocal cost-effectiveness signal: evidence from the HERO trial von Welch, Charlie, Forster, Martin, Ronaldson, Sarah, Keding, Ada, Corbacho-Martín, Belen, Tharmanathan, Puvan

Volltext

Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammation von Dillon, Magnus T, Guevara, Jeane, Mohammed, Kabir, Patin, Emmanuel C, Smith, Simon A, Dean, Emma, Jones, Gemma N, Willis, Sophie E, Petrone, Marcella, Silva, Carlos, Thway, Khin, Bunce, Catey, Roxanis, Ioannis, Nenclares, Pablo, Wilkins, Anna, McLaughlin, Martin, Jayme-Laiche, Adoracion, Benafif, Sarah, Nintos, Georgios, Kwatra, Vineet, Grove, Lorna, Mansfield, David, Proszek, Paula, Martin, Philip, Moore, Luiza, Swales, Karen E, Banerji, Udai, Saunders, Mark P, Spicer, James, Forster, Martin D, Harrington, Kevin J

Volltext

The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancer von Steventon, Luke, Man, Kenneth K C, Nicum, Shibani, Miller, Rowan E, Peleg Hasson, Shira, Shah, Samixa, Baser, Michael, Kipps, Emma, Forster, Martin D, Almossawi, Ofran, Chambers, Pinkie

Volltext

Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study von Forster, Martin D., Dillon, Magnus T., Kocsis, Judit, Remenár, Éva, Pajkos, Gabor, Rolland, Frederic, Greenberg, Jonathan, Harrington, Kevin J.

Volltext

A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer von Pruis, Melinda A, Krebs, Matthew G, Plummer, Ruth, De Vos, Filip, Angevin, Eric, Prenen, Hans, Forster, Martin D, Clack, Glen, Van der Aa, Annegret, Tjwa, Marc, Jansen, Ellen, Perera, Timothy, Lolkema, Martijn P

Volltext

Immune Checkpoint Inhibition in Head and Neck Cancer von Forster, Martin David, Devlin, Michael-John

Volltext

The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective cohort study von Steventon, Luke, Kipps, Emma, Man, Kenneth KC, Roylance, Rebecca, Forster, Martin D., Wong, Ian CK, Baser, Michael, Miller, Rowan E, Nicum, Shibani, Shah, Samixa, Almossawi, Ofran, Chambers, Pinkie

Volltext

Disulfonated tetraphenyl chlorin (TPCS2a )-induced photochemical internalisation of bleomycin in patients with solid malignancies: a phase 1, dose-escalation, first-in-man trial von Sultan, Ahmed A, PhD, Jerjes, Waseem, PhD, Berg, Kristian, Prof, Høgset, Anders, PhD, Mosse, Charles A, PhD, Hamoudi, Rifat, PhD, Hamdoon, Zaid, PhD, Simeon, Celia, BSc, Carnell, Dawn, MD, Forster, Martin, PhD, Hopper, Colin, Dr

Volltext

An inflammation based score can optimize the selection of patients with advanced cancer considered for early phase clinical trials von Pinato, David J, Stavraka, Chara, Flynn, Michael J, Forster, Martin D, O'Cathail, Séan M, Seckl, Michael J, Kristeleit, Rebecca S, Olmos, David, Turnbull, Samantha J, Blagden, Sarah P

Volltext